Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Breast Cancer

Free Subscription 31.08.2026 1 Ann Oncol 6 Ann Surg Oncol 1 BMJ 6 Breast Cancer 1 Breast Cancer (Dove Med Press) 1 Breast Cancer Res 2 Breast J 1 Cancer 6 Clin Breast Cancer 1 Clin Cancer Res 1 Eur J Cancer 1 Eur J Surg Oncol 1 Gene 1 J Biol Chem 1 J Clin Invest 1 J Clin Oncol 1 J Natl Cancer Inst 3 Lancet Oncol 1 NPJ Breast Cancer 1 Oncogene 2 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Oncol

1. GARBER JE, Cameron D, Campbell C, Yothers G, et al
   Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
   Ann Oncol. 2026 Aug 24:S0923-7534(26)01456-0. doi: 10.1016/j.annonc.2026.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

2. CLARKE P, Pessoa EC, Coelho BA, de Araujo Brito Buttros D, et al
   Cavity Margins Sample Shaving as Part of Extended Vacuum-Assisted Breast Biopsy: A Potential Approach to Predict Percutaneous Breast Cancer Excision.
   Ann Surg Oncol. 2026 Aug 28. doi: 10.1245/s10434-026-20464.
   PubMed         Abstract available
   
   
3. BECK AC, Carroll EF, Mukhtar RA, Cassidy MR, et al
   ASO Visual Abstract: Multidisciplinary Management Considerations in Invasive Lobular Breast Cancer: It Isn't Just Ductal.
   Ann Surg Oncol. 2026 Aug 28. doi: 10.1245/s10434-026-20455.
   PubMed        
   
   
4. STRAUSS E, Hyman J, Paluch-Shimon S, Breuer S, et al
   Fertility Preservation Pathways in Young Women With Breast Cancer: A Single-Center Analysis in a Publicly Funded System.
   Ann Surg Oncol. 2026 Aug 26. doi: 10.1245/s10434-026-20414.
   PubMed         Abstract available
   
   
5. AMBURN T, Louie D, Schwartz S, McFarlane A, et al
   Increased Axillary Nodal Metastasis in Patients with Breast Cancer and Limited English Proficiency.
   Ann Surg Oncol. 2026 Aug 24. doi: 10.1245/s10434-026-20422.
   PubMed         Abstract available
   
   
6. CONROY MM, Gaur KS, Rein LE, Szabo A, et al
   A Population Based Analysis of Breast Cancer Outcomes Among Disaggregated Asian American and Pacific Islander Women.
   Ann Surg Oncol. 2026 Aug 22. doi: 10.1245/s10434-026-20451.
   PubMed         Abstract available
   
   
7. SETO A, Port E, Bernik S, Sheng T, et al
   ASO Author Reflections: Radiologic Assessment of Residual Axillary Lymphadenopathy in Locally Advanced Breast Cancer After Neoadjuvant Therapy.
   Ann Surg Oncol. 2026 Aug 21. doi: 10.1245/s10434-026-20439.
   PubMed        
   
   

   
   BMJ

8. CASASSUS B
   Cosmic radiation and breast cancer: Flight attendant's disease was triggered by high altitude working conditions, court rules.
   BMJ. 2026;394:e100705.
   PubMed        
   
   

   
   Breast Cancer

9. LI X, Xin X, Xiong W, Zhang H, et al
   The value of LAR in predicting neoadjuvant therapy response and prognosis in HER2-positive breast cancer.
   Breast Cancer. 2026 Aug 24. doi: 10.1007/s12282-026-01892.
   PubMed         Abstract available
   
   
10. HAYASAKA R, Tanakura K, Kuramoto Y, Imai T, et al
    Indocyanine green fluorescence angiography algorithm for determining additional anastomosis in deep inferior epigastric perforator flap for breast reconstruction.
    Breast Cancer. 2026;33:1206-1213.
    PubMed         Abstract available
    
    
11. KATSURAGI R, Zaha H, Abe N, Orihara S, et al
    Therapeutic mammoplasty in selected East Asian patients: oncologic safety and cosmetic outcomes.
    Breast Cancer. 2026;33:1194-1205.
    PubMed         Abstract available
    
    
12. SAKAMOTO N, Matsui H, Fukuma E
    Comparison of ultrasound visibility and retrieval success of two ultrasound-visible clips in targeted axillary dissection after neoadjuvant chemotherapy.
    Breast Cancer. 2026;33:1173-1182.
    PubMed         Abstract available
    
    
13. NAKANO K, Shien T, Doihara H, Takahashi Y, et al
    Breast ultrasound screening in young adult women undergoing infertility treatment at an infertility clinic: a retrospective observational study.
    Breast Cancer. 2026;33:1093-1101.
    PubMed         Abstract available
    
    
14. POPESCU BV, Simon L, Blaye C, Marchi S, et al
    BRCA pathogenic variants and response in early TNBC patients treated with neoadjuvant pembrolizumab: outcomes of the BRCAPATH study.
    Breast Cancer. 2026;33:1059-1069.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Dove Med Press)

15. ATALAH F, Acarbay A, Karakok A, Nazli I, et al
    MCV-Neutropenia Risk Score and Overall Survival in HR+/HER2- Advanced Breast Cancer: A Multicenter Retrospective Landmark Analysis.
    Breast Cancer (Dove Med Press). 2026;18:624272.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res

16. NICOLA C, Peter E, Villagran-Garcia M, Treilleux I, et al
    Vascular and mesenchymal signatures of breast cancers associated with Yo and Ri paraneoplastic syndrome.
    Breast Cancer Res. 2026;28:148.
    PubMed         Abstract available
    
    

    
    Breast J

17. FU B, Yao Y, Liang W, Wang Y, et al
    Inhibition of miR-301a-3p Expression Promotes Ferroptosis: A New Target for Ferroptosis Treatment in TNBC.
    Breast J. 2026;2026:e9941495.
    PubMed         Abstract available
    
    
18. KOUNIAVSKI E, Gilron S, Lemberger M, Ciobotaro P, et al
    An Algorithm for Salvage of Implant-Threatening Complications in Breast Reconstruction.
    Breast J. 2026;2026:e4668584.
    PubMed         Abstract available
    
    

    
    Cancer

19. PASSERA R, Fabbro E, Zamagni G
    The burden of male breast cancer (MBC) in the GBD Central, Eastern, and Western Europe Regions from 1990 to 2023: Results from the Global Burden of Disease Study 2023.
    Cancer. 2026;132:e70585.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

20. IJAZ K, Alston B, Bevers T, Arun B, et al
    The Effect of Germline Pathogenic Variants in the Upgrade Rate to Breast Cancer Among Patients Diagnosed With Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ on Core Needle Biopsy.
    Clin Breast Cancer. 2026;26:193-198.
    PubMed         Abstract available
    
    
21. HUDSON-PHILLIPS SP, Nanda A, Attia M, Al Yaqout W, et al
    The Impact of Expanded Access to Germline High Penetrance Genetic Testing for Women With a New Diagnosis of Invasive Breast Cancer or High-Grade DCIS.
    Clin Breast Cancer. 2026;26:179-185.
    PubMed         Abstract available
    
    
22. LIN CJ, Krzyz EZ
    The Role of Technology in the Care of Breast-Cancer Related Lymphedema: A Scoping Review.
    Clin Breast Cancer. 2026;26:164-170.
    PubMed         Abstract available
    
    
23. PAN Y, Zheng C, Zheng D, Pan Y, et al
    CTSG Suppresses Breast Cancer Progression by Inhibiting the EGFR/ERK Signaling Pathway and Enhancing CD8(+) T Cell Activation.
    Clin Breast Cancer. 2026;26:154-163.
    PubMed         Abstract available
    
    
24. VON ARX C, Calabrese A, Piezzo M, Di Lauro V, et al
    CDK4/6i in the Underrepresented Histological Subtypes of HR+/-/HER2- Metastatic Breast Cancer: A Real-World Cohort Study of Effectiveness and Safety.
    Clin Breast Cancer. 2026;26:145-153.
    PubMed         Abstract available
    
    
25. HARBOUR S, Ki M, Chen C, Dai V, et al
    Implementation of Targeted Axillary Dissection in Clinically Node-Positive Breast Cancer: Adoption Trends and Comparative Outcomes at a Single Institution.
    Clin Breast Cancer. 2026;26:137-144.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

26. RUGO HS, Tolaney SM, Chan N, Borges G, et al
    Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE.
    Clin Cancer Res. 2026 Aug 24. doi: 10.1158/1078-0432.CCR-26-1816.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

27. POGGIO F, Generali D
    Methodological considerations in the interpretation of ASCENT-03.
    Eur J Cancer. 2026;245:116962.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

28. NING GOH SS, Aitchison LP, Le-An Aitchison J, Barry P, et al
    Preventing common shape deformities and complications in therapeutic mammoplasty: A practical guide.
    Eur J Surg Oncol. 2026;52:111990.
    PubMed         Abstract available
    
    

    
    Gene

29. SAMUEL BA, Jubie S, Jawahar N, Namboori PK, et al
    Role of estrogen receptor alpha in the regulation of breast cancer progression: signaling pathways and therapeutic implications.
    Gene. 2026 Aug 28:150376. doi: 10.1016/j.gene.2026.150376.
    PubMed         Abstract available
    
    

    
    J Biol Chem

30. SWAROOP B SS, Gopinath P, Kanumuri R, Seetharaman A, et al
    PAK1 mediated phosphorylation of ARGLU1 promotes tumorigenic potential of Breast cancer.
    J Biol Chem. 2026 Aug 25:113491. doi: 10.1016/j.jbc.2026.113491.
    PubMed         Abstract available
    
    

    
    J Clin Invest

31. LI X, Chen T, Zhao W, Li J, et al
    FBXW5 blunts RIGI/MDA5-IFN signaling to drive immunoevasion and chemo-immune resistance in triple-negative breast cancer models.
    J Clin Invest. 2026 Aug 25:e201573. doi: 10.1172/JCI201573.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

32. CASWELL-JIN JL, Somerfield MR, Khan MA, Kimmick GG, et al
    Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.
    J Clin Oncol. 2026 Aug 26:101200JCO2602034. doi: 10.1200/JCO-26-02034.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

33. ZAHWE M, Znaor A, Bardot A, Joshi S, et al
    Benchmarking female breast cancer survival in africa, Central and South america, and asia (SURVCAN-3).
    J Natl Cancer Inst. 2026 Aug 22:djag294. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Lancet Oncol

34. LARA GONZALEZ LE, Giudici F, Salgado R, Yan H, et al
    Manual, digital, and AI tumour-infiltrating lymphocyte scoring: a secondary analysis of the APHINITY randomised trial.
    Lancet Oncol. 2026;27:1168-1180.
    PubMed         Abstract available
    
    
35. DIXON-DOUGLAS JR, Drubay D, Salgado R, Acs B, et al
    Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.
    Lancet Oncol. 2026;27:1181-1192.
    PubMed         Abstract available
    
    
36. GUNSTER JLB, Tramm T, Machiels M, Demaria S, et al
    Tumour-infiltrating lymphocytes and breast radiotherapy: perspectives from the International Immuno-Oncology Biomarker Working Group.
    Lancet Oncol. 2026;27:e420-e433.
    PubMed         Abstract available
    
    

    
    NPJ Breast Cancer

37. YANG Z, Liu Y, Bai T, Biguri A, et al
    DynamicBUS: restoring temporal dynamics from static ultrasound for improved breast cancer diagnosis.
    NPJ Breast Cancer. 2026;12:112.
    PubMed         Abstract available
    
    

    
    Oncogene

38. HU M, Peng H, Qiu G, Liu S, et al
    Decitabine suppresses triple-negative breast cancer by disrupting DNMT1 liquid-liquid phase separation and synergizes with G9a inhibition.
    Oncogene. 2026 Aug 26. doi: 10.1038/s41388-026-03971.
    PubMed         Abstract available
    
    

    
    PLoS One

39. KLAIHMON P, Muangtate P, Thongphayong S, Saetan P, et al
    NECTIN2 depletion impairs migration and invasion in MDA-MB-231 breast cancer cells through LIMK1-associated cytoskeletal remodeling.
    PLoS One. 2026;21:e0356726.
    PubMed         Abstract available
    
    
40. ALZATE D, Sanchez AY, Pacheco Y, Isaza Ruget M, et al
    Exome-based cancer driver gene comprehensive testing can provide a genetic diagnosis for individuals with triple-negative breast cancer.
    PLoS One. 2026;21:e0356762.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

41. WEDEL S, Claveras Cabezudo A, Rauh O, Olkhova E, et al
    Lysophospholipid-TRPV1 interactions in chemotherapy-induced neuropathy.
    Proc Natl Acad Sci U S A. 2026;123:e2613615123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum